Mark Pletcher 6/9/2011 Prognostic and Genetic Tests.
Management of Advanced Stage Hodgkin Lymphoma Michael Crump, MD, FRCPC Princess Margaret Hospital University of Toronto Toronto, Canada.
DLBCL Matthew Cheung Sunnybrook Health Sciences Centre November 2011.
Malcolm Moore Professor of Medicine and Pharmacology, Princess Margaret Hospital, University of Toronto, Toronto, Canada Director of the Bras Family New.
HIGH DOSE RADIOTHERAPY IN THE TREATMENT OF PLEURAL MESOTHELIOMA AFTER PLEURECTOMY/DECORTICATION OR BIOPSY: LONG TERM FOLLW UP, ACUTE AND LATE TOXICITY.
Terapia Neoadiuvante Revisione delle evidenze scientifiche Valentina Guarneri Nonantola, 19 Novembre 2011.
Ductal Carcinoma In Situ (DCIS) JoAnne Zujewski, MD Head, Breast Cancer Therapeutics Clinical Investigations Branch Cancer Therapy Evaluation Program Division.
Association Radiothérapie-Hormonothérapie Cancers localisés et localement avancés de la prostate Michel Bolla, Camille Verry Clinique Universitaire de.
CRITICAL READING OF THE LITERATURE RELEVANT POINTS: - End points (including the one used for sample size) - Surrogate end points - Quality of the performed.
MYC-associated and Double Hit Lymphomas Lisa G Roth, MD Division of Hematology/Oncology Weill Cornell Medical College New York, NY.
Abstract 238 Primary Results of ROSE, A Randomized Placebo Controlled Phase III Trial Evaluating the Addition of Ramucirumab to First-Line Docetaxel Chemotherapy.